Medindia

X

Catasys Reports Second Quarter 2016 Financial Results

Tuesday, August 16, 2016 General News J E 4
Advertisement
Revenue grew 159% year-over-year; deferred revenue grew 66% in the first half of 2016

CATASYS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(unaudited)

Six Months Ended

(In thousands)

June 30,

2016

2015

Operating activities:

Net loss

$       (9,012)

$          (847)

Adjustments to reconcile net income (loss) to net cash used in operating activities:

   Depreciation and amortization

64

63

   Amortization of debt discount and issuance costs included in interest expense

660

1,056

   Provision for doubtful account

20

75

   Deferred rent

(45)

(34)

   Share-based compensation expense

349

1,037

   Common stock issued for consulting services

-

172

   Warrants issued for services

-

56

   Loss on exchange of warrants

-

4,410

   Fair value adjustment on warrant liability

750

(9,908)

   Fair value adjustment on derivative liability

2,844

-

Changes in current assets and liabilities:

   Receivables

(339)

230

   Prepaids and other current assets

245

118

   Deferred revenue

1,118

499

   Accounts payable and other accrued liabilities

397

478

      Net cash used in operating activities 

$       (2,949)

$       (2,595)

Investing activities:

   Purchases of property and equipment

$            (26)

$            (16)

   Deposits and other assets

16

-

      Net cash used in investing activities

$            (10)

$            (16)

Financing activities:

   Proceeds from the issuance of convertible debenture

$                -

$         2,000

   Proceeds from bridge loan

2,185

250

   Transaction Costs

-

(185)

   Capital lease obligations

(90)

(10)

     Net cash provided by financing activities

$         2,095

$         2,055

Net decrease in cash and cash equivalents

$          (864)

$          (556)

Cash and cash equivalents at beginning of period

916

708

Cash and cash equivalents at end of period

$              52

$            152

Supplemental disclosure of cash paid

   Income taxes

$              37

$              34

Supplemental disclosure of non-cash activity

   Property and equipment acquired through capital leases and other financing

$              43

$                -

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Athletes and mosquito protection
S
Regen BioPharma, Inc. Receives New Preliminary Hem...